You are here » Home » Companies » Company Overview » Hester Biosciences Ltd

Hester Biosciences Ltd.

BSE: 524669 Sector: Health care
NSE: HESTERBIO ISIN Code: INE782E01017
BSE LIVE 15:40 | 22 Sep 1024.25 -61.35
(-5.65%)
OPEN

1073.60

HIGH

1073.60

LOW

1001.95

NSE 15:31 | 22 Sep 1030.75 -36.90
(-3.46%)
OPEN

1067.65

HIGH

1074.00

LOW

1002.40

OPEN 1073.60
PREVIOUS CLOSE 1085.60
VOLUME 4916
52-Week high 1233.00
52-Week low 666.00
P/E 34.77
Mkt Cap.(Rs cr) 872
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 1073.60
CLOSE 1085.60
VOLUME 4916
52-Week high 1233.00
52-Week low 666.00
P/E 34.77
Mkt Cap.(Rs cr) 872
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Hester Biosciences Ltd. (HESTERBIO) - Company History

Incorporated as a private limited company in Apr.'87, Hester Pharmaceutical (HPL) was converted into a public limited company in Nov.'93. HPL markets and distributes veterinary and pharmaceutical products like animal health products, poultry vaccines, poultry diagnostic, laboratory kits and reagents. It markets the veterinary products of many international companies including Ghen Corporation, Japan; Maine Biological Laboratories, US; Idexx Corporation, US; International Diagnostic Systems Corporation, US; Biogal Galed Laboratories, Israel; and Kemin Europa, Belgium. The company's own production of veterinary vaccines (in Vials) is expected to commence soon. HPL has technical collaborations with Maine Biological Laboratories and Ghen Corporation. During 1996-97, company successfully implemented veterinary vaccine and commercial production has begun. The company has received licenses for producing 10 additional poultry vaccines.It has also signed an manufacturing agreement with Sinsui Inc for producing poultry vaccines.